World Health Organization Clinical Charts and Tables

Clinical Staging and Classification

• WHO Clinical Staging of HIV for Adults and Adolescents with Confirmed HIV Infection
  
• WHO Clinical Staging of HIV/AIDS for Children with Confirmed HIV Infection
  
• WHO Classification of HIV-Associated Clinical Disease in Adults
  
• CD4 Criteria for Severe HIV Immunodeficiency in Children
  

HIV Diagnosis in Children

• WHO Recommendations on Methods for Establishing the Presence of HIV Infection in Infants and Children
  
• Establishing Presence of HIV Infection in HIV Exposed Children Aged Under 18 Months in Resource-Limited Settings to Facilitate ART and HIV Care
  

Cotrimoxazole Prophylaxis

• WHO Recommendations for Prophylaxis for HIV-Related Infections in Exposed Infants and Children
  
• Co-trimoxazole Formulations and Dosage for Infants and Children Living with HIV or Exposed to HIV
  
• Starting Cotrimoxazole Prophylaxis for Adults and Adolescents Living with HIV
  

Initiating Antiretroviral Treatment in Adults

• WHO Recommendations for Initiating ARV Treatment in Pregnant Women
  
• WHO Recommendations for Initiating ART in Adults and Adolescents
  
• WHO CD4 Criteria for the Initiation of ART in Adults and Adolescents
  
• Initiating First-Line ART in Relationship to Starting Anti-TB Therapy
  

Initiating Antiretroviral Treatment in Children

• WHO Recommendations for Initiating Antiretroviral Treatment in Infants and Children
  
  Table: CD4 Criteria for Severe HIV Immunodeficiency
  Table: TLC Criteria for Severe HIV Immunodeficiency Requiring Initiation of ART
• Recommendations for the Timing of ART Following the Initiation of TB Treatment with a Rifampicin-Containing Regimen in HIV-Infected Infants and Children
  

Antiretroviral Drug Dosing

• Dosages of Antiretroviral Drugs for Adults and Adolescents
  
• Body Surface Area Estimation Tables for Children Using Weight Alone
  
• Pediatric Dosages for Antiretroviral Drugs
  

Managing Antiretroviral Treatment - Adults

• WHO Recommended Baseline Clinical and Laboratory Assessments for Adults and Adolescents
  
• WHO Recommended Minimum Frequency of Laboratory Tests for Monitoring in Resource-Limited Settings
  
• Toxicities of First-Line ARVs and Recommended Drug Substitutions
  
• Clinical Staging Events to Guide Decision-Making on Switching ART Regimen
  
• Detailed Recommendations for Switching to Second-Line ARV Regimens in Adults and Adolescents
  

Managing Antiretroviral Treatment - Children

• Laboratory Parameters for Monitoring Infants and Children at Baseline, Before and During ART
  
• Decision-Making on Switching to Second-Line Therapy for Treatment Failure Based on Availability of CD4 Measurement
  
• Using the WHO Pediatric Clinical Staging Events to Guide Decision-Making on Switching to Second-Line Therapy for Treatment Therapy
  
• Recommended Second-Line Regimens in Infant and Children in the Event of Treatment Failure of First-Line Regimes